secwatch.observer — SEC 8-K summary
======================================

Issuer:     TuHURA Biosciences, Inc./NV (HURA)
CIK:        0001498382
Form:       8-K
Filed at:   2024-09-03T23:59:59+00:00
Accession:  0000950170-24-102932
Event type: m_and_a
Sentiment:  negative
Materiality: 1.00
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kintara warns stockholder vote failure could lead to bankruptcy, delisting
--------------------------------------------------------------------------

- Voting deadline for merger with TuHURA is Sept 19, 2024 at 11:59 p.m. ET; special meeting Sept 20.
- If Proposals 3 & 5 don't get majority support, merger cannot close; company may lack capital and seek bankruptcy.
- Without approval, common stock likely delisted from Nasdaq Capital Market.
- Upon merger close, each share/warrant gets one contingent value right (CVR) tied to REM-001 program milestone.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1498382/000095017024102932/0000950170-24-102932-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1498382/000095017024102932/ktra-20240903.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-102932

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer